foxo4 dri cancer The disordered p53 transactivation domain is the target of and the senolytic compound FOXO4-DRI foxo4-dri senolytic peptide human trial
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

























